STAT3 and lung carcinoma: There is evidence that abnormally activated STAT3 has been found in a variety of cancers, including lung cancer, which leads to the inactivation of apoptotic pathways and the resistance of cancer cells to radiotherapy and chemotherapy [15,16,17].